Viral Vector Production (Research-use)-Global Market Status and Trend Report 2016-2026
Report Summary
Viral Vector Production (Research-use)-Global Market Status and Trend Report 2016-2026 offers a comprehensive analysis on Viral Vector Production (Research-use) industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Viral Vector Production (Research-use) 2016-2021, and development forecast 2022-2026
Main manufacturers/suppliers of Viral Vector Production (Research-use) worldwide, with company and product introduction, position in the Viral Vector Production (Research-use) market
Market status and development trend of Viral Vector Production (Research-use) by types and applications
Cost and profit status of Viral Vector Production (Research-use), and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Viral Vector Production (Research-use) market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Viral Vector Production (Research-use) industry.
The report segments the global Viral Vector Production (Research-use) market as:
Global Viral Vector Production (Research-use) Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2016-2026):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Viral Vector Production (Research-use) Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2016-2026):
Adeno-associated virus (AAV)
Lentivirus
Adenovirus
Retrovirus
Others
Global Viral Vector Production (Research-use) Market: Application Segment Analysis (Consumption Volume and Market Share 2016-2026; Downstream Customers and Market Analysis)
Cell & Gene Therapy Development
Vaccine Development
Biopharmaceutical and Pharmaceutical Discovery
Biomedical Research
Global Viral Vector Production (Research-use) Market: Manufacturers Segment Analysis (Company and Product introduction, Viral Vector Production (Research-use) Sales Volume, Revenue, Price and Gross Margin):
Merck KGaA
Lonza
FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
Cobra Biologics Ltd.
Thermo Fisher Scientific
Waisman Biomanufacturing
Genezen
YPOSKESI
Advanced BioScience Laboratories, Inc. (ABL, Inc.)
Novasep Holding S.A.S
Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.)
Vigene Biosciences, Inc.
General Electric Company (GE Healthcare)
CEVEC Pharmaceuticals GmbH
Batavia Biosciences B.V.
Biovion oy
Wuxi AppTec Co., Ltd.
VGXI, Inc.
Catalent Inc.
Miltenyi Biotec GmbH
SIRION Biotech GmbH
Virovek Incorporation
BioNTech IMFS GmbH
VIVEbiotech S.L.
Creative Biogene
Vibalogics GmbH
Takara Bio.
Cell and Gene Therapy Catapult
BlueBird Bio
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Viral Vector Production (Research-use)-Global Market Status and Trend Report 2016-2026 offers a comprehensive analysis on Viral Vector Production (Research-use) industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Viral Vector Production (Research-use) 2016-2021, and development forecast 2022-2026
Main manufacturers/suppliers of Viral Vector Production (Research-use) worldwide, with company and product introduction, position in the Viral Vector Production (Research-use) market
Market status and development trend of Viral Vector Production (Research-use) by types and applications
Cost and profit status of Viral Vector Production (Research-use), and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Viral Vector Production (Research-use) market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Viral Vector Production (Research-use) industry.
The report segments the global Viral Vector Production (Research-use) market as:
Global Viral Vector Production (Research-use) Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2016-2026):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Viral Vector Production (Research-use) Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2016-2026):
Adeno-associated virus (AAV)
Lentivirus
Adenovirus
Retrovirus
Others
Global Viral Vector Production (Research-use) Market: Application Segment Analysis (Consumption Volume and Market Share 2016-2026; Downstream Customers and Market Analysis)
Cell & Gene Therapy Development
Vaccine Development
Biopharmaceutical and Pharmaceutical Discovery
Biomedical Research
Global Viral Vector Production (Research-use) Market: Manufacturers Segment Analysis (Company and Product introduction, Viral Vector Production (Research-use) Sales Volume, Revenue, Price and Gross Margin):
Merck KGaA
Lonza
FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
Cobra Biologics Ltd.
Thermo Fisher Scientific
Waisman Biomanufacturing
Genezen
YPOSKESI
Advanced BioScience Laboratories, Inc. (ABL, Inc.)
Novasep Holding S.A.S
Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.)
Vigene Biosciences, Inc.
General Electric Company (GE Healthcare)
CEVEC Pharmaceuticals GmbH
Batavia Biosciences B.V.
Biovion oy
Wuxi AppTec Co., Ltd.
VGXI, Inc.
Catalent Inc.
Miltenyi Biotec GmbH
SIRION Biotech GmbH
Virovek Incorporation
BioNTech IMFS GmbH
VIVEbiotech S.L.
Creative Biogene
Vibalogics GmbH
Takara Bio.
Cell and Gene Therapy Catapult
BlueBird Bio
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF VIRAL VECTOR PRODUCTION (RESEARCH-USE)
1.1 Definition of Viral Vector Production (Research-use) in This Report
1.2 Commercial Types of Viral Vector Production (Research-use)
1.2.1 Adeno-associated virus (AAV)
1.2.2 Lentivirus
1.2.3 Adenovirus
1.2.4 Retrovirus
1.2.5 Others
1.3 Downstream Application of Viral Vector Production (Research-use)
1.3.1 Cell & Gene Therapy Development
1.3.2 Vaccine Development
1.3.3 Biopharmaceutical and Pharmaceutical Discovery
1.3.4 Biomedical Research
1.4 Development History of Viral Vector Production (Research-use)
1.5 Market Status and Trend of Viral Vector Production (Research-use) 2016-2026
1.5.1 Global Viral Vector Production (Research-use) Market Status and Trend 2016-2026
1.5.2 Regional Viral Vector Production (Research-use) Market Status and Trend 2016-2026
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Viral Vector Production (Research-use) 2016-2021
2.2 Production Market of Viral Vector Production (Research-use) by Regions
2.2.1 Production Volume of Viral Vector Production (Research-use) by Regions
2.2.2 Production Value of Viral Vector Production (Research-use) by Regions
2.3 Demand Market of Viral Vector Production (Research-use) by Regions
2.4 Production and Demand Status of Viral Vector Production (Research-use) by Regions
2.4.1 Production and Demand Status of Viral Vector Production (Research-use) by Regions 2016-2021
2.4.2 Import and Export Status of Viral Vector Production (Research-use) by Regions 2016-2021
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Viral Vector Production (Research-use) by Types
3.2 Production Value of Viral Vector Production (Research-use) by Types
3.3 Market Forecast of Viral Vector Production (Research-use) by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Viral Vector Production (Research-use) by Downstream Industry
4.2 Market Forecast of Viral Vector Production (Research-use) by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF VIRAL VECTOR PRODUCTION (RESEARCH-USE)
5.1 Global Economy Situation and Trend Overview
5.2 Viral Vector Production (Research-use) Downstream Industry Situation and Trend Overview
CHAPTER 6 VIRAL VECTOR PRODUCTION (RESEARCH-USE) MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Viral Vector Production (Research-use) by Major Manufacturers
6.2 Production Value of Viral Vector Production (Research-use) by Major Manufacturers
6.3 Basic Information of Viral Vector Production (Research-use) by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Viral Vector Production (Research-use) Major Manufacturer
6.3.2 Employees and Revenue Level of Viral Vector Production (Research-use) Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 VIRAL VECTOR PRODUCTION (RESEARCH-USE) MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Merck KGaA
7.1.1 Company profile
7.1.2 Representative Viral Vector Production (Research-use) Product
7.1.3 Viral Vector Production (Research-use) Sales, Revenue, Price and Gross Margin of Merck KGaA
7.2 Lonza
7.2.1 Company profile
7.2.2 Representative Viral Vector Production (Research-use) Product
7.2.3 Viral Vector Production (Research-use) Sales, Revenue, Price and Gross Margin of Lonza
7.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
7.3.1 Company profile
7.3.2 Representative Viral Vector Production (Research-use) Product
7.3.3 Viral Vector Production (Research-use) Sales, Revenue, Price and Gross Margin of FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
7.4 Cobra Biologics Ltd.
7.4.1 Company profile
7.4.2 Representative Viral Vector Production (Research-use) Product
7.4.3 Viral Vector Production (Research-use) Sales, Revenue, Price and Gross Margin of Cobra Biologics Ltd.
7.5 Thermo Fisher Scientific
7.5.1 Company profile
7.5.2 Representative Viral Vector Production (Research-use) Product
7.5.3 Viral Vector Production (Research-use) Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific
7.6 Waisman Biomanufacturing
7.6.1 Company profile
7.6.2 Representative Viral Vector Production (Research-use) Product
7.6.3 Viral Vector Production (Research-use) Sales, Revenue, Price and Gross Margin of Waisman Biomanufacturing
7.7 Genezen
7.7.1 Company profile
7.7.2 Representative Viral Vector Production (Research-use) Product
7.7.3 Viral Vector Production (Research-use) Sales, Revenue, Price and Gross Margin of Genezen
7.8 YPOSKESI
7.8.1 Company profile
7.8.2 Representative Viral Vector Production (Research-use) Product
7.8.3 Viral Vector Production (Research-use) Sales, Revenue, Price and Gross Margin of YPOSKESI
7.9 Advanced BioScience Laboratories, Inc. (ABL, Inc.)
7.9.1 Company profile
7.9.2 Representative Viral Vector Production (Research-use) Product
7.9.3 Viral Vector Production (Research-use) Sales, Revenue, Price and Gross Margin of Advanced BioScience Laboratories, Inc. (ABL, Inc.)
7.10 Novasep Holding S.A.S
7.10.1 Company profile
7.10.2 Representative Viral Vector Production (Research-use) Product
7.10.3 Viral Vector Production (Research-use) Sales, Revenue, Price and Gross Margin of Novasep Holding S.A.S
7.11 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.)
7.11.1 Company profile
7.11.2 Representative Viral Vector Production (Research-use) Product
7.11.3 Viral Vector Production (Research-use) Sales, Revenue, Price and Gross Margin of Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.)
7.12 Vigene Biosciences, Inc.
7.12.1 Company profile
7.12.2 Representative Viral Vector Production (Research-use) Product
7.12.3 Viral Vector Production (Research-use) Sales, Revenue, Price and Gross Margin of Vigene Biosciences, Inc.
7.13 General Electric Company (GE Healthcare)
7.13.1 Company profile
7.13.2 Representative Viral Vector Production (Research-use) Product
7.13.3 Viral Vector Production (Research-use) Sales, Revenue, Price and Gross Margin of General Electric Company (GE Healthcare)
7.14 CEVEC Pharmaceuticals GmbH
7.14.1 Company profile
7.14.2 Representative Viral Vector Production (Research-use) Product
7.14.3 Viral Vector Production (Research-use) Sales, Revenue, Price and Gross Margin of CEVEC Pharmaceuticals GmbH
7.15 Batavia Biosciences B.V.
7.15.1 Company profile
7.15.2 Representative Viral Vector Production (Research-use) Product
7.15.3 Viral Vector Production (Research-use) Sales, Revenue, Price and Gross Margin of Batavia Biosciences B.V.
7.16 Biovion oy
7.17 Wuxi AppTec Co., Ltd.
7.18 VGXI, Inc.
7.19 Catalent Inc.
7.20 Miltenyi Biotec GmbH
7.21 SIRION Biotech GmbH
7.22 Virovek Incorporation
7.23 BioNTech IMFS GmbH
7.24 VIVEbiotech S.L.
7.25 Creative Biogene
7.26 Vibalogics GmbH
7.27 Takara Bio.
7.28 Cell and Gene Therapy Catapult
7.29 BlueBird Bio
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF VIRAL VECTOR PRODUCTION (RESEARCH-USE)
8.1 Industry Chain of Viral Vector Production (Research-use)
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF VIRAL VECTOR PRODUCTION (RESEARCH-USE)
9.1 Cost Structure Analysis of Viral Vector Production (Research-use)
9.2 Raw Materials Cost Analysis of Viral Vector Production (Research-use)
9.3 Labor Cost Analysis of Viral Vector Production (Research-use)
9.4 Manufacturing Expenses Analysis of Viral Vector Production (Research-use)
CHAPTER 10 MARKETING STATUS ANALYSIS OF VIRAL VECTOR PRODUCTION (RESEARCH-USE)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Viral Vector Production (Research-use) in This Report
1.2 Commercial Types of Viral Vector Production (Research-use)
1.2.1 Adeno-associated virus (AAV)
1.2.2 Lentivirus
1.2.3 Adenovirus
1.2.4 Retrovirus
1.2.5 Others
1.3 Downstream Application of Viral Vector Production (Research-use)
1.3.1 Cell & Gene Therapy Development
1.3.2 Vaccine Development
1.3.3 Biopharmaceutical and Pharmaceutical Discovery
1.3.4 Biomedical Research
1.4 Development History of Viral Vector Production (Research-use)
1.5 Market Status and Trend of Viral Vector Production (Research-use) 2016-2026
1.5.1 Global Viral Vector Production (Research-use) Market Status and Trend 2016-2026
1.5.2 Regional Viral Vector Production (Research-use) Market Status and Trend 2016-2026
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Viral Vector Production (Research-use) 2016-2021
2.2 Production Market of Viral Vector Production (Research-use) by Regions
2.2.1 Production Volume of Viral Vector Production (Research-use) by Regions
2.2.2 Production Value of Viral Vector Production (Research-use) by Regions
2.3 Demand Market of Viral Vector Production (Research-use) by Regions
2.4 Production and Demand Status of Viral Vector Production (Research-use) by Regions
2.4.1 Production and Demand Status of Viral Vector Production (Research-use) by Regions 2016-2021
2.4.2 Import and Export Status of Viral Vector Production (Research-use) by Regions 2016-2021
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Viral Vector Production (Research-use) by Types
3.2 Production Value of Viral Vector Production (Research-use) by Types
3.3 Market Forecast of Viral Vector Production (Research-use) by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Viral Vector Production (Research-use) by Downstream Industry
4.2 Market Forecast of Viral Vector Production (Research-use) by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF VIRAL VECTOR PRODUCTION (RESEARCH-USE)
5.1 Global Economy Situation and Trend Overview
5.2 Viral Vector Production (Research-use) Downstream Industry Situation and Trend Overview
CHAPTER 6 VIRAL VECTOR PRODUCTION (RESEARCH-USE) MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Viral Vector Production (Research-use) by Major Manufacturers
6.2 Production Value of Viral Vector Production (Research-use) by Major Manufacturers
6.3 Basic Information of Viral Vector Production (Research-use) by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Viral Vector Production (Research-use) Major Manufacturer
6.3.2 Employees and Revenue Level of Viral Vector Production (Research-use) Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 VIRAL VECTOR PRODUCTION (RESEARCH-USE) MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Merck KGaA
7.1.1 Company profile
7.1.2 Representative Viral Vector Production (Research-use) Product
7.1.3 Viral Vector Production (Research-use) Sales, Revenue, Price and Gross Margin of Merck KGaA
7.2 Lonza
7.2.1 Company profile
7.2.2 Representative Viral Vector Production (Research-use) Product
7.2.3 Viral Vector Production (Research-use) Sales, Revenue, Price and Gross Margin of Lonza
7.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
7.3.1 Company profile
7.3.2 Representative Viral Vector Production (Research-use) Product
7.3.3 Viral Vector Production (Research-use) Sales, Revenue, Price and Gross Margin of FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
7.4 Cobra Biologics Ltd.
7.4.1 Company profile
7.4.2 Representative Viral Vector Production (Research-use) Product
7.4.3 Viral Vector Production (Research-use) Sales, Revenue, Price and Gross Margin of Cobra Biologics Ltd.
7.5 Thermo Fisher Scientific
7.5.1 Company profile
7.5.2 Representative Viral Vector Production (Research-use) Product
7.5.3 Viral Vector Production (Research-use) Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific
7.6 Waisman Biomanufacturing
7.6.1 Company profile
7.6.2 Representative Viral Vector Production (Research-use) Product
7.6.3 Viral Vector Production (Research-use) Sales, Revenue, Price and Gross Margin of Waisman Biomanufacturing
7.7 Genezen
7.7.1 Company profile
7.7.2 Representative Viral Vector Production (Research-use) Product
7.7.3 Viral Vector Production (Research-use) Sales, Revenue, Price and Gross Margin of Genezen
7.8 YPOSKESI
7.8.1 Company profile
7.8.2 Representative Viral Vector Production (Research-use) Product
7.8.3 Viral Vector Production (Research-use) Sales, Revenue, Price and Gross Margin of YPOSKESI
7.9 Advanced BioScience Laboratories, Inc. (ABL, Inc.)
7.9.1 Company profile
7.9.2 Representative Viral Vector Production (Research-use) Product
7.9.3 Viral Vector Production (Research-use) Sales, Revenue, Price and Gross Margin of Advanced BioScience Laboratories, Inc. (ABL, Inc.)
7.10 Novasep Holding S.A.S
7.10.1 Company profile
7.10.2 Representative Viral Vector Production (Research-use) Product
7.10.3 Viral Vector Production (Research-use) Sales, Revenue, Price and Gross Margin of Novasep Holding S.A.S
7.11 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.)
7.11.1 Company profile
7.11.2 Representative Viral Vector Production (Research-use) Product
7.11.3 Viral Vector Production (Research-use) Sales, Revenue, Price and Gross Margin of Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.)
7.12 Vigene Biosciences, Inc.
7.12.1 Company profile
7.12.2 Representative Viral Vector Production (Research-use) Product
7.12.3 Viral Vector Production (Research-use) Sales, Revenue, Price and Gross Margin of Vigene Biosciences, Inc.
7.13 General Electric Company (GE Healthcare)
7.13.1 Company profile
7.13.2 Representative Viral Vector Production (Research-use) Product
7.13.3 Viral Vector Production (Research-use) Sales, Revenue, Price and Gross Margin of General Electric Company (GE Healthcare)
7.14 CEVEC Pharmaceuticals GmbH
7.14.1 Company profile
7.14.2 Representative Viral Vector Production (Research-use) Product
7.14.3 Viral Vector Production (Research-use) Sales, Revenue, Price and Gross Margin of CEVEC Pharmaceuticals GmbH
7.15 Batavia Biosciences B.V.
7.15.1 Company profile
7.15.2 Representative Viral Vector Production (Research-use) Product
7.15.3 Viral Vector Production (Research-use) Sales, Revenue, Price and Gross Margin of Batavia Biosciences B.V.
7.16 Biovion oy
7.17 Wuxi AppTec Co., Ltd.
7.18 VGXI, Inc.
7.19 Catalent Inc.
7.20 Miltenyi Biotec GmbH
7.21 SIRION Biotech GmbH
7.22 Virovek Incorporation
7.23 BioNTech IMFS GmbH
7.24 VIVEbiotech S.L.
7.25 Creative Biogene
7.26 Vibalogics GmbH
7.27 Takara Bio.
7.28 Cell and Gene Therapy Catapult
7.29 BlueBird Bio
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF VIRAL VECTOR PRODUCTION (RESEARCH-USE)
8.1 Industry Chain of Viral Vector Production (Research-use)
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF VIRAL VECTOR PRODUCTION (RESEARCH-USE)
9.1 Cost Structure Analysis of Viral Vector Production (Research-use)
9.2 Raw Materials Cost Analysis of Viral Vector Production (Research-use)
9.3 Labor Cost Analysis of Viral Vector Production (Research-use)
9.4 Manufacturing Expenses Analysis of Viral Vector Production (Research-use)
CHAPTER 10 MARKETING STATUS ANALYSIS OF VIRAL VECTOR PRODUCTION (RESEARCH-USE)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
